Cargando…
MicroRNA-504 modulates osteosarcoma cell chemoresistance to cisplatin by targeting p53
Chemoresistance implicates the therapeutic value of cisplatin and remains a primary obstacle to its clinical use. MicroRNAs (miRs) negatively modulate the expression of their target genes and are associated with the occurrence and progression of various types of tumor. The abnormal expression of miR...
Autores principales: | Chen, Xin, Lv, Chen, Zhu, Xiongbai, Lin, Wenjun, Wang, Lu, Huang, Zhengxiang, Yang, Shengwu, Sun, Junying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341607/ https://www.ncbi.nlm.nih.gov/pubmed/30675226 http://dx.doi.org/10.3892/ol.2018.9749 |
Ejemplares similares
-
Salidroside suppresses the growth and invasion of human osteosarcoma cell lines MG63 and U2OS in vitro by inhibiting the JAK2/STAT3 signaling pathway
por: Huang, Lintuo, et al.
Publicado: (2019) -
Analysis of miR-148b expression differences in stage-I and II parosteal osteosarcoma
por: Lin, Wenjun, et al.
Publicado: (2018) -
Obesity, Independent of p53 Gene Dosage, Promotes Mammary Tumor Progression and Upregulates the p53 Regulator MicroRNA-504
por: Ford, Nikki A., et al.
Publicado: (2013) -
TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma
por: Li, Cuiyun, et al.
Publicado: (2018) -
MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATβ in osteosarcoma
por: Song, L., et al.
Publicado: (2017)